CVE-2018-14786 describes an improper authentication vulnerability in Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, GH, CC, and TIVA) versions 2.3.6 and prior. This critical vulnerability, with a CVSS score of 9.4, allows a remote attacker to gain unauthorized access and impact pump operation when connected to a terminal server via the serial port. The attack requires no privileges or user interaction and has low attack complexity, leading to potential high impact on confidentiality, integrity, and availability. While no active exploitation or public exploit code (Metasploit, Nuclei, ExploitDB) has been identified, and community discussion is minimal, the high FAUCET Risk Score of 85/100 indicates significant potential risk.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
<= 2.3.6CPE matchmatch criteria | cpe:2.3:o:bd:alaris_gs_firmware:*:*:*:*:*:*:*:* | ||
<= 2.3.6CPE matchmatch criteria | cpe:2.3:o:bd:alaris_gh_firmware:*:*:*:*:*:*:*:* | ||
<= 2.3.6CPE matchmatch criteria | cpe:2.3:o:bd:alaris_cc_firmware:*:*:*:*:*:*:*:* | ||
<= 2.3.6CPE matchmatch criteria | cpe:2.3:o:bd:alaris_tiva_firmware:*:*:*:*:*:*:*:* |
CVSS version used by this source: 3.0
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.3 Bluesky, 0.3 Mastodon, and 2.4 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.